CD8A and neoplasm: In the 4T1 tumor-bearing mouse models, it was confirmed that FD/FM@siTOXNPs had significant advantages in enhancing the effect of ICD, significantly increasing the expression of cytokines perforin (PRF), IFN- γ and granzyme-B in CD8+T cells and inhibiting the depletion of CD8+T cells.